Drugmaker Sun Pharmaceutical Industries Ltd said on Friday that it received Indian regulatory approval to start clinical trials of pancreatitis drug nafamostat mesilate in COVID-19 patients.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indias-sun-pharma-to-conduct-clinical-trial-of-pancreatitis-drug-in-covid-19-patients/articleshow/76089435.cms

Source : The Economic Times

Link : https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indias-sun-pharma-to-conduct-clinical-trial-of-pancreatitis-drug-in-covid-19-patients/articleshow/76089435.cms